Overview
Product name | Recombinant SARS-COV-2 NSP7&NSP8 Protein |
---|
Catalog No. | RP02651 |
---|
Description | SARS-COV-2 NSP7&NSP8 Protein is expressed from E.coil with His tag at the C-terminal.;It contains Ser1-Gln83(NSP7)&Ala1-Gln198(NSP8). |
---|
Purity | > 95% as determined by Tris-Bis PAGE |
---|
Endotoxin | Less than 1EU per μg by the LAL method. |
---|
Species | SARS-CoV-2 |
---|
Calculated MW | 32.8 kDa |
---|
Background
The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. The crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19.
Product information
Synonym | SP7&NSP8; nsp7&nsp8 |
---|
Expression Host | E. coli |
---|
Tag | C-His |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.